In about 4–8% of CHD-APAH patients, PAH-related, pathogenic variants have been identified, particularly in the two transcription factors T-box factor 4 (TBX4) and the SRY box transcription factor 17 (SOX17)7,8,16. The gene discussed is TBX4; the disease is pulmonary arterial hypertension.